Deferred Tax Assets, Valuation Allowance of Nascent Biotech Inc. from 31 Mar 2014 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Nascent Biotech Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2014 to 31 Mar 2024.
  • Nascent Biotech Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2024 was $1,238,858, a 30% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Nascent Biotech Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $1,238,858 -$518,925 -30% 31 Mar 2024 10-K 01 Jul 2024 2024 FY
Q1 2023 $1,757,783 +$1,437,903 +450% 31 Mar 2023 10-K 01 Jul 2024 2024 FY
Q1 2022 $319,880 +$146,965 +85% 31 Mar 2022 10-K/A 03 Jul 2023 2023 FY
Q1 2021 $172,915 -$2,198,779 -93% 31 Mar 2021 10-K 15 Jun 2022 2022 FY
Q1 2020 $2,371,694 +$4,134,770 31 Mar 2020 10-K 08 Jul 2021 2021 FY
Q1 2019 $1,763,076 -$3,290,824 -215% 31 Mar 2019 10-K 22 Jun 2020 2020 FY
Q1 2018 $1,527,748 -$307,878 -17% 31 Mar 2018 10-K 12 Jul 2019 2019 FY
Q1 2017 $1,835,626 -$469,361 -20% 31 Mar 2017 10-K 29 Jun 2018 2018 FY
Q1 2016 $2,304,987 +$3,982,968 31 Mar 2016 10-K 29 Jun 2017 2017 FY
Q1 2015 $1,677,981 -$716,954 -75% 31 Mar 2015 10-K 14 Jul 2016 2016 FY
Q1 2014 $961,027 31 Mar 2014 10-K 02 Jul 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.